GPT Healthcare logo

GPT Healthcare MD, chairman, board of directors and AGM

NSE: GPTHEALTHBSE: 544131Healthcare ServicesSmall Cap

Last close ₹130.96down ₹2.59 (1.94%)BSE ₹131.95

Share price at the NSE close on 23 Oct 2026. Previous close ₹133.55.

52-week range of traded prices to 23 Oct 2026
₹115.00Low, 27 Mar 2026₹175.00High, 31 Jul 2026
Market cap
₹1,075 Cr1,433rd largest listed
P/E
22.7
P/B
4.0
Dividend yield
1.91%
ROE
18.3%
ROCE
22.1%
Debt to equity
0.06
Volume, NSE
92,16451.5% delivered

GPT Healthcare board of directors

At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.

  • Chairperson and managing directorOm TantiaRelated to the promoter
  • Company Secretary and Compliance OfficerAnkur Sharma

10 directors5 independent2 executive3 non-executive

  • Om Tantia · Chairperson and managing directorExecutive · joined Jan 2005 · reappointed Apr 2024 · 2 listed boards
  • Shree Gopal TantiaNon-executive · joined Sep 2025 · reappointed Sep 2025 · 2 listed boards
  • Anurag TantiaExecutive · joined Oct 2011 · reappointed Oct 2024 · 1 listed board · 1 committee seat
  • Aruna TantiaNon-executive · joined Apr 2005 · reappointed Apr 2005 · 1 listed board
  • Ghanshyam GoyalNon-executive · joined Apr 2006 · reappointed Apr 2006 · 1 listed board
  • Kashi Prasad KhandelwalIndependent · joined Sep 2023 · reappointed Sep 2023 · 33 months as independent · 4 listed boards · 4 as independent · 8 committee seats, 4 as chair
  • Tapti SenIndependent · joined Sep 2021 · reappointed Sep 2021 · 57 months as independent · 1 listed board · 1 as independent · 1 committee seat
  • Hari ModiIndependent · joined Sep 2021 · reappointed Sep 2021 · 57 months as independent · 2 listed boards · 2 as independent · 2 committee seats, 2 as chair
  • Deepak PramanikIndependent · joined Sep 2023 · reappointed Sep 2023 · 33 months as independent · 1 listed board · 1 as independent · 1 committee seat, 1 as chair
  • Amrendra Prasad VermaIndependent · joined Sep 2023 · reappointed Sep 2023 · 33 months as independent · 2 listed boards · 2 as independent · 2 committee seats

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

1 director who left
  • Dwarika Prasad Tantia, left 17 Aug 2025: Others

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 18 May 20269 of 10 present4 independent · 104 days in between
    • 2 Feb 202610 of 10 present5 independent

  • Audit Committee

    Chair Deepak Pramanik

    Kashi Prasad Khandelwal, Amrendra Prasad Verma

    • 18 May 20263 of 3 present3 independent · 104 days in between
    • 2 Feb 20263 of 3 present3 independent

  • Nomination and remuneration committee

    Chair Kashi Prasad Khandelwal

    Tapti Sen, Hari Modi

    • 18 May 20262 of 3 present2 independent · 104 days in between
    • 2 Feb 20263 of 3 present3 independent

  • Stakeholders Relationship Committee

    Chair Hari Modi

    Tapti Sen, Anurag Tantia

    • 17 Jan 20263 of 3 present2 independent

  • Corporate Social Responsibility Committee

    Chair Om Tantia

    Aruna Tantia, Tapti Sen

    • 18 May 20263 of 3 present1 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • S.R. Batliboi & Co. LLPPeer-review certificate valid to Jul 2027

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

GPT Healthcare AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.GPT Healthcare dividend history

Annual general meeting, 6 Aug 2026

61,544 shareholders on the register on 30 Jul 2026; present: 7 promoters and 59 others; votes counted by Ashok Kumar Daga / Ashok Kumar Daga.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the audited financial statements of the Company as at and for the financial year ended March 31, 2026 together with Reports of Board of Directors and Auditors thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 5.57%

    Turnout: all 70.89% · promoters 100.00% · institutions 59.94% · other public 0.14%

  2. To confirm the payment of Interim Dividend of Rs 1 (10%) per Equity Share of Rs10 each, and to declare Final Dividend of Rs1.50 (15%) per Equity Share of Rs10 each for the financial year 2025-26
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 5.30%

    Turnout: all 70.89% · promoters 100.00% · institutions 59.94% · other public 0.14%

  3. To appoint a Director in place of Dr. Aruna Tantia (DIN: 00001347), who retires by rotation at this Annual General Meeting and being eligible, offers herself for re-appointment
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 5.88%

    Turnout: all 70.88% · promoters 100.00% · institutions 59.94% · other public 0.14%

  4. To ratify the Remuneration of Cost Auditors for the FY 2026-27
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 6.08%

    Turnout: all 70.89% · promoters 100.00% · institutions 59.94% · other public 0.14%

  5. To consider approval for increase in remuneration of Dr. Mridul Tantia, “Vice President” and a relative of Director holding office or place of profit
    OrdinaryPromoters have an interest in it
    99.93% for0.07% against

    Against: promoters 0.00% · institutions 0.92% · other public 9.02%

    Turnout: all 70.88% · promoters 100.00% · institutions 59.94% · other public 0.12%

  6. To consider approval of payment of Professional Fees to Dr. Niharika Tantia, Consultant and a relative of Director holding office or place of profit
    OrdinaryPromoters have an interest in it
    99.93% for0.07% against

    Against: promoters 0.00% · institutions 0.92% · other public 7.80%

    Turnout: all 70.88% · promoters 100.00% · institutions 59.94% · other public 0.14%

  7. To consider Re-appointment of Mr. Hari Modi (DIN: 00801413) as an Independent Director of the Company
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.02% · other public 6.08%

    Turnout: all 70.89% · promoters 100.00% · institutions 59.94% · other public 0.14%

  8. To consider Re-appointment of Dr. Tapti Sen (DIN: 06730644) as an Independent Director of the Company
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.02% · other public 6.08%

    Turnout: all 70.89% · promoters 100.00% · institutions 59.94% · other public 0.14%

  9. To consider continuation of Directorship of Mr. Amrendra Prasad Verma (DIN: 00236108) as a Non Executive Independent Director of the Company on completion of 75 years of age
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.02% · other public 6.08%

    Turnout: all 70.89% · promoters 100.00% · institutions 59.94% · other public 0.14%

  10. To consider payment of Doctor Consultancy Fees to Dr. Ghanshyam Goyal (DIN: 00234246), Non Executive Director of the Company for the financial year 2026-27
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.02% · other public 6.08%

    Turnout: all 70.89% · promoters 100.00% · institutions 59.94% · other public 0.14%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 27 Oct 2025, 2 resolutions

68,149 shareholders on the register on 19 Sep 2025; votes counted by Ashok Kumar Daga / Ashok Kumar Daga.The company's voting result (opens in a new tab)

  1. Alteration of Articles of Association of the Company
    Special
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.02% · other public 7.70%

    Turnout: all 70.26% · promoters 100.00% · institutions 52.80% · other public 0.19%

  2. Appointment of Mr. Shree Gopal Tantia, Promoter (DIN:00001346) as a Director (Non-Executive and Non- Independent) of the Company
    SpecialPromoters have an interest in it
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 7.70%

    Turnout: all 70.26% · promoters 100.00% · institutions 52.80% · other public 0.19%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 5 Aug 2025, 10 resolutions

68,841 shareholders on the register on 29 Jul 2025; present: 7 promoters and 54 others; votes counted by Ashok Kumar Daga / Ashok Kumar Daga.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the audited financial statements of the Company as at and for the financial year ended March 31, 2025 together with Reports of Board of Directors and Auditors thereon.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 4.00%

    Turnout: all 71.66% · promoters 100.00% · institutions 54.16% · other public 0.35%

  2. To confirm payment of Interim Dividend of Rs 1(10%) per Equity Shares of face value of Rs 10 each, and to declare Final Dividend of Rs 1.50 per Equity Shares for the financial year 2024-25.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 3.76%

    Turnout: all 71.66% · promoters 100.00% · institutions 54.16% · other public 0.35%

  3. To appoint a Director in place of Dr. Ghanshyam Goyal (DIN:00234246), who retires by rotation at this Annual General Meeting and being eligible, offers himself for re-appointment.
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 4.63%

    Turnout: all 71.66% · promoters 100.00% · institutions 54.16% · other public 0.35%

  4. To consider the appointment of Mr. Ashok Kumar Daga, Company Secretary in Practice as Secretarial Auditors of the Company for a period of 5 years from financial year 2025-2026 to 2029-2030.
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 4.60%

    Turnout: all 71.66% · promoters 100.00% · institutions 54.16% · other public 0.35%

  5. To ratify the Remuneration of Cost Auditors for the FY 2025-26.
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 4.60%

    Turnout: all 71.66% · promoters 100.00% · institutions 54.16% · other public 0.35%

  6. To consider variation in terms and conditions of employment of Mr. Dwarika Prasad Tantia, Executive Chairman.
    SpecialPromoters have an interest in it
    99.76% for0.24% against

    Against: promoters 0.00% · institutions 2.78% · other public 4.60%

    Turnout: all 71.66% · promoters 100.00% · institutions 54.16% · other public 0.35%

  7. To consider variation in terms and conditions of employment of Mr. Anurag Tantia, Executive Director.
    SpecialPromoters have an interest in it
    99.76% for0.24% against

    Against: promoters 0.00% · institutions 2.78% · other public 4.60%

    Turnout: all 71.66% · promoters 100.00% · institutions 54.16% · other public 0.35%

  8. To consider variation in terms of payment of Doctor Consultancy Fees to Dr. Aruna Tantia, Non-Executive Non-Independent Director.
    SpecialPromoters have an interest in it
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 4.72%

    Turnout: all 71.49% · promoters 100.00% · institutions 52.65% · other public 0.35%

  9. To consider payment of Doctor Consultancy Fees to Dr. Ghanshyam Goyal, Non-Executive Director of the Company for the financial year 2025-26.
    Special
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 4.72%

    Turnout: all 71.49% · promoters 100.00% · institutions 52.65% · other public 0.35%

  10. To consider continuation of Directorship of Mr. Kashi Prasad Khandelwal as a Non-Executive Independent Director of the Company on completion of 75 years of age.
    Special
    95.61% for4.39% against

    Against: promoters 0.00% · institutions 52.31% · other public 4.60%

    Turnout: all 71.66% · promoters 100.00% · institutions 54.16% · other public 0.35%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 25 Jul 2024, 10 resolutions

Present: 4 promoters and 78 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the audited standalone financial statements of the Company as at and for the Financial Year ended March 31, 2024 together with Reports of Board of Directors and Auditors thereonMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 2.87%

    Turnout: all 77.99% · promoters 100.00% · institutions 61.04% · other public 0.23%

  2. To confirm payment of Interim Dividends of Rs. 2 per Equity Shares of face value of Rs. 10 each, and to declare Final Dividend of Rs. 1.50 per Equity Shares for the financial year 2023-24.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 4.58%

    Turnout: all 77.99% · promoters 100.00% · institutions 61.04% · other public 0.23%

  3. To appoint a Director in place of Dr. Aruna Tantia (DIN: 00001347), who retires by rotation and being eligible, offers herself for re-appointment.
    OrdinaryPromoters have an interest in it
    97.93% for2.07% against

    Against: promoters 0.00% · institutions 13.00% · other public 4.46%

    Turnout: all 77.99% · promoters 100.00% · institutions 61.04% · other public 0.23%

  4. To consider the appointment of S R Batliboi & Co LLP, Chartered Accountants (Firm Registration No. 301003E/E300005) as Statutory Auditors of the Company in place of Singhi & Co, Chartered Accountants (Firm Registration No. 302049E), the retiring Statutory Auditors.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 3.24%

    Turnout: all 77.99% · promoters 100.00% · institutions 61.04% · other public 0.23%

  5. To ratify the Remuneration of Cost Auditors for the FY 2024-25.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 3.45%

    Turnout: all 77.99% · promoters 100.00% · institutions 61.04% · other public 0.23%

  6. Fixation of charges for service of documents through a particular mode, if requested by a shareholder.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 3.87%

    Turnout: all 77.99% · promoters 100.00% · institutions 61.04% · other public 0.23%

  7. Reappointment of Mr. Dwarika Prasad Tantia as Executive Chairman.
    SpecialPromoters have an interest in it
    96.45% for3.55% against

    Against: promoters 0.00% · institutions 22.33% · other public 5.40%

    Turnout: all 77.99% · promoters 100.00% · institutions 61.04% · other public 0.23%

  8. Reappointment of Mr. Anurag Tantia as Executive Director.
    SpecialPromoters have an interest in it
    96.63% for3.37% against

    Against: promoters 0.00% · institutions 21.23% · other public 5.59%

    Turnout: all 77.99% · promoters 100.00% · institutions 61.04% · other public 0.23%

  9. Revision of Remuneration of Mrs. Kriti Tantia as Chief Financial Officer (CFO), holding place of profit in the company in terms of Section 188(1)(f) of the Companies Act, 2013.
    SpecialPromoters have an interest in it
    94.56% for5.44% against

    Against: promoters 0.00% · institutions 34.23% · other public 6.84%

    Turnout: all 77.99% · promoters 100.00% · institutions 61.04% · other public 0.23%

  10. Payment of Professional Fees i.e. Doctors Consultancy Fees to Dr. Ghanshyam Goyal, Non-Executive Director of the Company.
    Special
    90.92% for9.08% against

    Against: promoters 0.00% · institutions 57.18% · other public 5.87%

    Turnout: all 77.99% · promoters 100.00% · institutions 61.04% · other public 0.23%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 9 May 2024, 1 resolution

The company's voting result (opens in a new tab)

  1. Continuation of Mr. Dwarika Prasad Tantia (DIN:00001341) as Chairman and Whole Time Director of the Company upon attaining the age of Seventy years
    SpecialPromoters have an interest in it
    97.34% for2.66% against

    Against: promoters 0.00% · institutions 17.13% · other public 10.04%

    Turnout: all 77.66% · promoters 100.00% · institutions 64.11% · other public 0.31%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.

Mutual fund votes, meeting of 27 Oct 2025, 2 fund houses

  • Alteration of Articles of Association of the Company
    Against Motilal Oswal Mutual Fund
    • Motilal Oswal Mutual FundCompliant with law. Governance concern: Proposed amendment in Article 121(a) undermines Board’s role in the election of Regular chairman and grants Promoters excessive participation is Board during.
    1 for1 against
  • Appointment of Mr. Shree Gopal Tantia, Promoter (DIN:00001346) as a Director (Non-Executive and Non- Independent) of the Company
    2 for0 against

Mutual fund votes, meeting of 5 Aug 2025, 3 fund houses

  • To receive, consider and adopt the audited financial statements of the Company as at and for the financial year ended March 31, 2025 together with Reports of Board of Directors and Auditors thereon.
    3 for0 against
  • To confirm payment of Interim Dividend of Rs 1(10%) per Equity Shares of face value of Rs 10 each, and to declare Final Dividend of Rs 1.50 per Equity Shares for the financial year 2024-25.
    3 for0 against
  • To appoint a Director in place of Dr. Ghanshyam Goyal (DIN:00234246), who retires by rotation at this Annual General Meeting and being eligible, offers himself for re-appointment.
    3 for0 against
  • To consider the appointment of Mr. Ashok Kumar Daga, Company Secretary in Practice as Secretarial Auditors of the Company for a period of 5 years from financial year 2025-2026 to 2029-2030.
    3 for0 against
  • To ratify the Remuneration of Cost Auditors for the FY 2025-26.
    3 for0 against
  • To consider variation in terms and conditions of employment of Mr. Dwarika Prasad Tantia, Executive Chairman.
    3 for0 against
  • To consider variation in terms and conditions of employment of Mr. Anurag Tantia, Executive Director.
    3 for0 against
  • To consider variation in terms of payment of Doctor Consultancy Fees to Dr. Aruna Tantia, Non-Executive Non-Independent Director.
    3 for0 against
  • To consider payment of Doctor Consultancy Fees to Dr. Ghanshyam Goyal, Non-Executive Director of the Company for the financial year 2025-26.
    3 for0 against
  • To consider continuation of Directorship of Mr. Kashi Prasad Khandelwal as a Non-Executive Independent Director of the Company on completion of 75 years of age.
    Against Axis Mutual Fund, Bandhan Mutual Fund
    • Axis Mutual FundKashi Prasad Khandelwal, 74, is a Chartered Accountant and proprietor at K. Khandelwal & Co. He has been on the board of the company since September 2021, and his current term ends in September 2028. The company seeks approval for his continuation on the board after he attains 75 years of age in March 2026, in line with regulations. We raise concern that he has been on the board of GPT Infraprojects Ltd. (a promoter-controlled company) since May 2017, and thus, his overall association with the group will exceed ten years in May 2027 (during his current term). Therefore, we do not support his continuation on the board as an Independent Director due to his long term association.
    • Bandhan Mutual FundCompliant with law. Governance concern: Proposed continuation may lead to prolonged association with the group; not served cooling off period at the time of appointment; NRC Chairman and Excessive remuneration proposed to single NED.
    1 for2 against
2 earlier meetings

Mutual fund votes, meeting of 25 Jul 2024, 3 fund houses

  • To receive, consider and adopt the audited standalone financial statements of the Company as at and for the Financial Year ended March 31, 2024 together with Reports of Board of Directors and Auditors thereonMoreLess
    3 for0 against
  • To confirm payment of Interim Dividends of Rs. 2 per Equity Shares of face value of Rs. 10 each, and to declare Final Dividend of Rs. 1.50 per Equity Shares for the financial year 2023-24.
    3 for0 against
  • To appoint a Director in place of Dr. Aruna Tantia (DIN: 00001347), who retires by rotation and being eligible, offers herself for re-appointment.
    Against Axis Mutual Fund
    • Axis Mutual FundDr. (Ms.) Aruna Tantia, 66, is part of promoter family. She has been Director in the company since 4 April 2005. She is associated with ILS Hospitals as a Senior Consultant (Gynaecology and Obstetrics) since 4 April 2005. She has experience of over 36 years as a medical practitioner.We have concerns about her attendance- hence we do not support the resolution.
    2 for1 against
  • To consider the appointment of S R Batliboi & Co LLP, Chartered Accountants (Firm Registration No. 301003E/E300005) as Statutory Auditors of the Company in place of Singhi & Co, Chartered Accountants (Firm Registration No. 302049E), the retiring Statutory Auditors.MoreLess
    3 for0 against
  • To ratify the Remuneration of Cost Auditors for the FY 2024-25.
    3 for0 against
  • Fixation of charges for service of documents through a particular mode, if requested by a shareholder.
    3 for0 against
  • Reappointment of Mr. Dwarika Prasad Tantia as Executive Chairman.
    Against Bandhan Mutual Fund
    • Bandhan Mutual FundCompliant with Law. Governance Concern: Holding positions of Board Chairperson and Executive Director may lead to concentration of power in the hands of a single person, no absolute cap on variable pay.
    2 for1 against
  • Reappointment of Mr. Anurag Tantia as Executive Director.
    Against Bandhan Mutual Fund
    • Bandhan Mutual FundCompliant with Law. No concern on the merit of the proposed appointee. Governance Concern: no absolute cap on variable pay/ overall pay.
    2 for1 against
  • Revision of Remuneration of Mrs. Kriti Tantia as Chief Financial Officer (CFO), holding place of profit in the company in terms of Section 188(1)(f) of the Companies Act, 2013.
    Against Axis Mutual Fund, Bandhan Mutual Fund
    • Axis Mutual FundMs. Kriti Tantia, daughter in law of Dwarika Prasad Tantia – Executive Chairperson, is Chief Financial Officer, GPT Healthcare Limited. She has been associated with the company since 1 May 2011 and was appointed as Chief Financial Officer on 15 March 2016. We have a concern that the resolution is enabling and is valid in perpetuity, therefore, given the uncapped nature of remuneration, future pay levels may be high, without requiring subsequent shareholder approval. Hence, we are unable to support the resolution.
    • Bandhan Mutual FundCompliant with law. Governance concern: Excess increment in proposed remuneration and non- disclosure of basis of remuneration.
    1 for2 against
  • Payment of Professional Fees i.e. Doctors Consultancy Fees to Dr. Ghanshyam Goyal, Non-Executive Director of the Company.
    Against Bandhan Mutual Fund, Kotak Mahindra Mutual Fund
    • Bandhan Mutual FundCompliant with law. Governance concern: Continuing executive without relinquishing executive position.
    • Kotak Mahindra Mutual FundThe Company is seeking shareholders approval to pay Doctor Consultancy Fees to Dr. Ghanshyam Goyal, NonExecutive Director, for the FY 2024-25. The Company has classified Dr. Goyal as a NED of the Company. However, Dr. Goyal still holds an executive position at the Company. Dr. Goyal is the Head of Department of Diabetology of Salt Lake hospital since the year 2000. Therefore, a governance concern has been raised with respect to his professional fees. Hence voting against.
    1 for2 against

Mutual fund votes, meeting of 9 May 2024, 3 fund houses

  • Continuation of Mr. Dwarika Prasad Tantia (DIN:00001341) as Chairman and Whole Time Director of the Company upon attaining the age of Seventy years
    Against Bandhan Mutual Fund
    • Bandhan Mutual FundContinuation of Appointment is compliant with law. Governance concern: Combined Position of Chairman & Whole-time Director.
    2 for1 against

Each fund house counted once, from its own disclosure; the reasons are its own words.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

None open at any quarter's end.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
No
The chair is related to the managing director
Yes
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
No
There was a cyber security incident in the quarter
No

The company's own answers in its filing.

How money raised was used

The company's results filing for the quarter to Jun 2026 says no statement of how money raised was used applies to it.